InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,794.66
(
0.00%
)
Post# of 77
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

vinnybotz

Send PM Follow Ignore
Followers 190
Posts 14069
Boards Moderated 0
Alias Born 08/21/2006

vinnybotz

Re: ShootinBlanks post# 24

Sunday, 08/21/2016 8:50:12 PM

Sunday, August 21, 2016 8:50:12 PM

Post# of 77
Proteo is currently setting up a pivotal phase III clinical trial for the prophylactic treatment of acute postoperative complications after resection of esophageal cancer, after a phase II multi-center trial had demonstrated that Elafin treated patients needed a significantly shorter stay in the intensive care unit as compared to placebo patients. In a further phase II study in patients undergoing coronary artery bypass surgery, a significant reduction of the circulating cardiac damage marker Troponin I at 6 hours after surgery was observed.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up